Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Loading...
Community
/
United States
/
Healthcare
/
Clover Health Investments
Create a narrative
Clover Health Investments Community
NasdaqGS:CLOV Community
3
Narratives
written by author
0
Comments
on narratives written by author
72
Fair Values set
on narratives written by author
Community Investing Ideas
Clover Health Investments
Popular
Undervalued
Overvalued
Clover Health Investments
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Rising Costs And Regulation Will Erode Medicare Advantage Profitability
Key Takeaways Persistent cost pressures, regulatory risks, and rising competition threaten both profitability and scalability, undermining Clover Health's growth strategies. Heavy reliance on membership expansion and external funding increases vulnerability to market downturns and shareholder dilution.
View narrative
US$2.50
FV
6.8% overvalued
intrinsic discount
20.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Clover Health Investments
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Digital Healthcare And Medicare Advantage Will Unlock Long-term Opportunities
Key Takeaways Clover's technology-driven care model and expanding platform could yield outsized membership growth, recurring revenue, and strengthened margins as competitors retreat from wide-network PPO offerings. Enhanced data access and platform initiatives may unlock significant multi-sided platform economics, positioning Clover for durable advantage amid industry shifts toward value-based reimbursement and home care.
View narrative
US$5.00
FV
46.6% undervalued
intrinsic discount
25.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Clover Health Investments
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Technology Adoption And Medicare Advantage Will Shape Healthcare's Future
Key Takeaways Technology-driven care model and data-driven tools enable lower costs, higher margins, and create new revenue opportunities amid the healthcare industry's shift toward value-based care. Focus on Medicare Advantage and efficiency improvements positions the company for sustained growth, increasing profitability, and long-term expansion.
View narrative
US$3.65
FV
26.8% undervalued
intrinsic discount
22.78%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
39
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
CLOV
CLOV
Clover Health Investments
Your Fair Value
US$
Current Price
US$2.67
62.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-487m
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.6b
Earnings US$278.5m
Advanced
Set Fair Value